Summary
Single intraperitoneal (i.p.) doses of 16 different drugs were given to mice 2 h before injecting scrapie i.p. Scrapie was injected as serial ten-fold dilutions of standard inocula and the effective titres obtained were used as a measure of the relative efficiency of infection in treated compared to saline injected mice. Despite the wide variety of drugs tested, most of them increased, non-specifically, the efficiency of infection by 0.6 to 2.1 log10 i.p. LD50 units (i.e., 4 to 126-fold), but only when both drug and scrapie were given i.p. The effect was greatest with a 2 h or a 6 h interval suggesting an involvement either of resident peritoneal cells or of elicited cells such as polymorphonuclear neutrophils. There was no increase in the efficiency of infection after intervals of 2 or 7 days when induced macrophages would predominate. The reverse sequence of injections (scrapie-0.5 h-drug) had no effect despite the persistence of high scrapie titre in the peritoneum at the time of drug injection. However, the effect was restored by a second injection of scrapie in the sequence,scrapie-drug-scrapie.
It is concluded that scrapie infection is established within minutes of injection but much of the inoculum is associated with peritoneal cells which are irrelevant to pathogenesis. Drugs may enhance the infection of relevant peritoneal cells or their targeting to the visceral lymphoreticular tissues where early replication takes place.
Similar content being viewed by others
References
Bruce ME (1985) Agent replication dynamics in a long incubation period model of mouse scrapie. J Gen Virol 66: 2517–2522
Bursuker I, Goldman R (1983) On the origin of macrophage heterogeneity: a hypothesis. J Reticuloendothelial Soc 33: 207–220
Carp RI, Callahan SM (1981) In vitro interaction of scrapie agent and mouse peritoneal macrophages. Intervirology 16: 8–13
Carp RI, Callahan SM (1982) Effect of mouse peritoneal macrophages on scrapie infectivity during extended in vitro incubation. Intervirology 17: 201–207
Carp RI, Callahan SM (1985) Effect of prior treatment with thioglycolate on the incubation period of intraperitoneally injected scrapie. Intervirology 24: 170–173
Clarke MC, Kimberlin RH (1984) Pathogenesis of mouse scrapie: distribution of agent in the pulp and stroma of infected spleens. Vet Microbiol 9: 215–225
Collis SC, Kimberlin RH (1985) Long-term persistence of scrapie infection in mouse spleens in the absence of clinical disease. FEMS Microbiol Lett 29: 111–114
Dickinson AG, Fraser H, McConnell I, Outram GW (1978) Mitogenic stimulation of the host enhances susceptibility to scrapie. Nature 272: 54–55
Ehlers B, Diringer H (1984) Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J Gen Virol 65: 1325–1330
Ehlers B, Rudolph R, Diringer H (1984) The reticuloendothelial system in scrapie pathogenesis. J Gen Virol 65: 423–428
Farquhar CF, Dickinson AG (1986) Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within a month before or after infection. J Gen Virol 67: 463–473
Fraser H, Dickinson AG (1978) Studies of the lymphoreticular system in the pathogenesis of scrapie: the role of spleen and thymus. J Comp Pathol 88: 563–573
Fraser H, Farquhar CF (1987) Ionising radiation has no influence on scrapie incubation period in mice. Vet Microbiol 13: 211–223
Gesner BM, Howard JG (1967) The isolation of lymphocytes and macrophages. In: Weir DM (ed) Handbook of experimental immunology. Blackwell, Oxford, pp 1009–1033
Hadlow WJ, Kennedy RC, Race RE (1982) Natural infection of Suffolk sheep with scrapie virus. J Infect Dis 146: 657–664
Hearst JE, Warr GA, Jakob GJ (1980) Characterisation of murine lung and peritoneal macrophages. J Reticuloendothelial Soc 27: 443–454
Hotchin J, Sikora E, Baker F (1983) Disappearance of scrapie virus from tissues of the mouse. Intervirology 19: 205–212
Kimberlin RH, Cunnington PG (1978) Reduction of scrapie incubation time in mice and hamsters by a single injection of methanol extraction residue of BCG. FEMS Microbiol Lett 3: 169–172
Kimberlin RH, Walker CA (1978) Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose-response curves. J Comp Pathol 88: 39–47
Kimberlin RH, Walker CA (1979) Antiviral compound effective against experimental scrapie. Lancet ii: 591–592
Kimberlin RH, Walker CA (1982) Pathogenesis of mouse scrapie: patterns of agent replication in different parts of the CNS following intraperitoneal infection. J R Soc Med 75: 618–624
Kimberlin RH, Walker CA (1983) Invasion of the CNS by scrapie agent and its spread to different parts of the brain In: Court LA, Cathala F (eds) Virus non conventionnels et affections du systeme nerveux central. Masson, Paris, pp 17–33
Kimberlin RH, Walker CA (1983) The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection. Arch Virol 78: 9–18
Kimberlin RH, Walker CA (1986) Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulphate and some other polyanions. Antimicrob Agents Chemother 30: 409–413
Kimberlin RH, Walker CA (1988) Pathogenesis of experimental scrapie. In: Bock G, Marsh J (eds) Novel infectious agents and the central nervous system. Wiley, Chichester, pp 37–62 (Ciba Foundation Symposium, vol 135)
Kimberlin RH, Walker CA (1988) Incubation periods in six models of intraperitoneally injected scrapie depend mainly on the dynamics of agent replication within the nervous system and not the lymphoreticular system. J Gen Virol 69: 2953–2960
Kimberlin RH, Walker CA (1989) Transport targeting and replication of scrapie in the CNS. In: Court L, Dormont D, Brown P, Kingsbury DT (eds) Unconventional virus diseases of the central nervous system. Commissariat a l'Energie Atomique, Fontenay-aux-Roses, France, pp 547–562
Kimberlin RH, Walker CA (1989) The role of the spleen in the neuroinvasion of scrapie in mice. Virus Res 12: 201–212
Kimberlin RH, Walker CA (1989) Pathogenesis of scrapie in mice after intragastric infection. Virus Res 12: 213–220
Kuroda Y, Gibbs CJ Jr, Amyx HL, Gajdusek DC (1983) Creutzfeldt-Jakob disease in mice: persistent viraemia and preferential replication of virus in low-density lymphocytes. Infect Immun 41: 154–161
Lavelle GC, Sturman L, Hadlow WJ (1972) Isolation from mouse spleen of cell populations with high specific infectivity for scrapie virus. Infect Immun 5: 319–323
McFarlin DE, Raff MC, Simpson E, Nehlsen SH (1971) Scrapie in immunologically deficient mice. Nature 233: 336
Marsh RF (1981) Effect of vaccinia-activated macrophages on scrapie infection in hamsters. In: Streilein JW, Hart DA, Stein-Streilein J, Ducan WR, Billingham RE (eds) Hamster immune responses in infectious and oncologic diseases. Plenum, New York, pp 359–363
Miller GA, Morahan PS, White S, Jessee E (1982) Functional and biochemical heterogeneity among subpopulations of rat and mouse peritoneal macrophages. J Reticuloendothelial Soc 32: 111–124
Millson GC, Kimberlin RH, Manning EJ, Collis SC (1979) Early distribution of radioactive liposomes and scrapie infectivity in mouse tissues following administration by different routes. Vet Microbiol 4: 89–99
Outram GW, Dickinson AG, Fraser H (1974) Reduced susceptibility to scrapie in mice after steroid administration. Nature 249: 855–856
Outram GW, Dickinson AG, Fraser H (1975) Slow encephalopathies, inflammatory responses and arachis oil. Lancet i: 198–200
Thomas MA, MacSween RNM (1981) Heterogeneity of rat peritoneal and alveolar macrophage populations: characterisation of their surface antigens by antisera. Br J Exp Pathol 62: 65–73
Worthington M, Clark R (1971) Lack of effect of immunosuppression on scrapie infection in mice. J Gen Virol 13: 349–351
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kimberlin, R.H., Walker, C.A. Intraperitoneal infection with scrapie is established within minutes of injection and is non-specifically enhanced by a variety of different drugs. Archives of Virology 112, 103–114 (1990). https://doi.org/10.1007/BF01348988
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01348988